You are here
The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.
Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point ofCare ApplicationsSBC: GENECAPTURE Topic: CBD15C001
GeneCapture, Inc. is proposing to develop a rapid in vitro diagnostic prototype using our patented molecular-based CAPTURE (ConfirmActive Pathogens Through Unamplified RNA Expression) assay. Based on the results and experience gained in our Phase I STTR contractHDTRA1-16C-0061: Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications, we p ...STTR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense
SBC: Mentis Sciences, Inc. Topic: DLA171002
Mentis Sciences Inc. proposes to develop Technical Data Packages and generate Source Approval Requests for critically needed components for the Air Launched Cruise Missile engine platform, the F107, which is no longer supported by the OEM. The supply of some spare parts may be exhausted as early as Oct 2018, on a system that is scheduled to remain in service through at least 2030.Mentis will work ...SBIR Phase II 2018 Department of DefenseDefense Logistics Agency
SBC: CREARE LLC Topic: CBD13109
Interfaces on existing military chemical/biological protection garments are not designed to fully eliminate macroscopic and microscopic air gaps at folds, fabric surfaces, or hook-and-loop closures, and thus do not provide a hermetic barrier against exposure. Creare is developing hermetic garment closure systems that seal macroscopic and microscopic gaps at interfaces and closures and provide high ...SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense